Showing results (441-450 of 525) with videos related to

Sort By:
Pageof 53
Clinical Chemistry|October 9, 2010
Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assaysDavid G Grenache, Dina N Greene, Anand S Dighe, et al.
Methods Report (RTI Press)|January 28, 2017
Tasty THC: Promises and Challenges of Cannabis EdiblesDaniel G Barrus, Kristen L Capogrossi, Sheryl C Cates, et al.
European Journal of Pharmacology|May 27, 2014
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodentsJenny L Wiley, D Matthew Walentiny, M Jerry Wright, et al.
Bioorganic & Medicinal Chemistry|January 23, 2003
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptorJohn W Huffman, Ross Mabon, Ming Jung Wu, et al.
Journal of the American Academy of Audiology|May 8, 2007
The impact of tinnitus on quality of life in older adultsDavid M Nondahl, Karen J Cruickshanks, Dayna S Dalton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2018
Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICAThomas F Gamage, Charlotte E Farquhar, Timothy W Lefever, et al.
Forensic Toxicology|August 22, 2017
In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICARichard C Kevin, Timothy W Lefever, Rodney W Snyder, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2018
Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid ReceptorsThomas F Gamage, Charlotte E Farquhar, Ryan J McKinnie, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indolesJohn W Huffman, Paul V Szklennik, Amanda Almond, et al.
Addiction Biology|April 21, 2012
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxietyJesse R Schank, Andrea L Goldstein, Kelly E Rowe, et al.
Pageof 53